Comparative, Randomized, Single-Dose, Bioavailability Study of Kali's Clonazepam ODT 1 mg With That of Klonopin Wafers 1 mg ODT in Healthy Adult Subjects Under Fasting Conditions.

NCT00652912 Phase 1 COMPLETED

To compare the single-dose bioavailability of Clonazepam ODT 1 mg and Klonopin Wafers 1 mg ODT

Details

Lead sponsor	Par Pharmaceutical, Inc.
Phase	Phase 1
Status	COMPLETED
Enrolment	32
Start date	2004-03
Completion	2004-05

Conditions

• To Determine Bioequivalence Under Fasting Conditions

Interventions

• Clonazepam
• Klonopin Wafers

Primary outcomes

• Rate and Extent of Absorption — 24 Hours